Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion
2014
A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib
2007
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
2008
18F-Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Adrenocortical Tumors: A Prospective Study in 77 Operated Patients
2009
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
AME Position Statement on adrenal incidentaloma
2011
HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/neu-Transgenic Mice
2003
CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer
2018
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Clinical management of adrenocortical carcinoma
2009
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
2016 Standout
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Prognostic Factors in Non-small Cell Lung Cancer
2002
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors
2015
Establishing the Diagnosis of Lung Cancer
2013 Standout
Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies
2014 Standout
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers
2003
Cancer to bone: a fatal attraction
2011 Standout
FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical Carcinoma
2011
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non–small‐cell lung cancer patients
2012
Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications
2014
Accuracy of several parameters of hypothalamic–pituitary–adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma
2010
Adrenal Incidentalomas: Diagnostic Evaluation and Long-Term Follow-up
2008
Guidelines on the radical management of patients with lung cancer
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor
2007
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Cushing's syndrome
2015 Standout
Lung Cancer
2008 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Potential Use of Bisphosphonates in the Prevention of Metastases in Early-Stage Breast Cancer
2007
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden
2012
The Management of Thymoma: A Systematic Review and Practice Guideline
2009
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee
2010
Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Cancer
2011
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs
2014
Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study
1997
The prevalence of adrenal incidentaloma in routine clinical practice
2011
Molecular mechanisms of cisplatin resistance
2011 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
2012
Pyroptosis: mechanisms and diseases
2021 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Cytogenetic and molecular aspects of lung cancer
2005
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Clonal Genetic Alterations in the Lungs of Current and Former Smokers
1997
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Benefits and Harms of CT Screening for Lung Cancer
2012
Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan
2003 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer
2013
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment
2012
Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
2016
Methods for Staging Non-small Cell Lung Cancer
2013
Functions and mechanisms of long noncoding RNAs in lung cancer
2016
Outcomes From 3144 Adrenalectomies in the United States
2009
Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
2003
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Metastasis Organotropism: Redefining the Congenial Soil
2019
British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
2015
Nonfunctional adrenal lesions without loss of signal intensity on MRI: Whose problem is it? The patient's? The surgeon's?
2012
Complications of lung resection and exercise capacity: A meta-analysis
2007
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial
2011
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
The Incidentally Discovered Adrenal Mass
2007
Efectividad diagnóstica de la tomografía por emisión de positrones con 18fluorodeoxiglucosa asociada a tomografía axial en la discriminación de benignidad o malignidad de las lesiones suprarrenales
2010
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
2008
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Combined Chemical Shift Imaging With Early Dynamic Serial Gadolinium-Enhanced MRI in the Characterization of Adrenal Lesions
2014
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
2013 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Nonsurgical management of malignant thymoma
1999
Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
2005
Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference
2008
Adrenocortical carcinoma: a clinician's update
2011
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
2009
Preoperative 18F‐FDG Uptake is Strongly Correlated with Malignancy, Weiss Score, and Molecular Markers of Aggressiveness in Adrenal Cortical Tumors
2011
MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis
2016
Adrenal lesion frequency: A prospective, cross-sectional CT study in a defined region, including systematic re-evaluation
2010
p53 and HER2/neu Expression in Relation to Chemotherapy Response in Patients with Non-Small Cell Lung Cancer
2006
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Diagnostic efficacy and discriminatory capacity of positron emission tomography combined with axial tomography of adrenal lesions
2010
Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas
2013
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
The Incidental Adrenal Mass on CT: Prevalence of Adrenal Disease in 1,049 Consecutive Adrenal Masses in Patients with No Known Malignancy
2008
Long-Term Follow-Up in Adrenal Incidentalomas: An Italian Multicenter Study
2014
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
PADGE: analysis of heterogeneous patterns of differential gene expression
2007
Beneficial Metabolic Effects of Prompt Surgical Treatment in Patients with an Adrenal Incidentaloma Causing Biochemical Hypercortisolism
2010
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of P. Borasio being referenced
Non–Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication Pathways
2009
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
2009
HER‐2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma
2002
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series
2006
Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience
1999
Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: Results in six patients
1993
Prognostic significance of Ki67 labelling in resected non small cell lung cancer
1993
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography☆
2009
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers
2005
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients☆
2008
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
2003
Low dose CT in early lung cancer diagnosis: Prevalence data.
2006
Gas exchange threshold as a predictor of severe postoperative complications after lung resection in mild-to-moderate chronic obstructive pulmonary disease.
1998
Bone Sialoprotein Is Predictive of Bone Metastases in Resectable Non–Small-Cell Lung Cancer: A Retrospective Case-Control Study
2006
Lung Cancer Stage is an Independent Risk Factor for Surgical Mortality
2008